Previous 10 | Next 10 |
Endo International (NASDAQ:ENDP) said it expects a Tennessee state court to grant a default judgment against it in regards to the company's sale of prescription opioids. Endo is a defendant in Dunaway, et al. v. Purdue Pharma, L.P., et al., which is pending in the Circuit Court for Cumberland...
Endo Comments on Default Judgment on Liability in Tennessee State Court Canada NewsWire DUBLIN ,, Feb. 11, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) today announced that it expects a Tennessee state court to issue an order granting...
Texas Attorney General Ken Paxton announced an opioid settlement worth $225M with Teva Pharmaceutical (TEVA -2.2%) on Monday. Per the terms, Teva (NYSE:TEVA) will also provide $75M of Narcan (naloxone hydrochloride injection), a prescription medication used in the treatment of effec...
Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles Canada NewsWire DUBLIN , Feb. 7, 2022 /CNW/ -- First and only manufacturer-prepared, FDA approved vasopressin in a premixed ready-to-use (RT...
Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results Canada NewsWire DUBLIN , Jan. 25, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth–quarter and full-year 2021 financial results on February 28, 2022 a...
Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims Canada NewsWire DUBLIN , Jan. 18, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceutica...
Paladin Labs Announces the Launch of Xydalba® (dalbavancin for injection) in Canada Canada NewsWire The new antibiotic treatment is for adult patients with acute bacterial skin and skin structure infections (ABSSSI) ³ MONTREAL , Jan. 17, 2022 ...
Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism Canada NewsWire DUBLIN , Jan. 13, 2022 /CNW/ -- Pharmac...
Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development Canada NewsWire DUBLIN , Jan. 11, 2022 /CNW/ -- Endo International ...
Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients: Watching Education Unfold Canada NewsWire DUBLIN , Jan. 10, 2022 /CNW/ -- The campaign features real Dupuytren's contracture (DC) patients and aims to address patient ...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...